tiprankstipranks
Cosciens Biopharma announces possible delay in filing 2024-end documents
PremiumThe FlyCosciens Biopharma announces possible delay in filing 2024-end documents
1M ago
COSCIENS Biopharma Advances Avenanthramides to Phase 2a Trial
Premium
Company Announcements
COSCIENS Biopharma Advances Avenanthramides to Phase 2a Trial
2M ago
Cosciens Biopharma announces initiation of Phase 2a study for avenanthramides
Premium
The Fly
Cosciens Biopharma announces initiation of Phase 2a study for avenanthramides
2M ago
COSCIENS Biopharma Restructures Board After Resignation
PremiumCompany AnnouncementsCOSCIENS Biopharma Restructures Board After Resignation
7M ago
Cosciens Biopharma director Carolyn Egbert resigns
Premium
The Fly
Cosciens Biopharma director Carolyn Egbert resigns
7M ago
COSCIENS Biopharma Welcomes New Board Director
Premium
Company Announcements
COSCIENS Biopharma Welcomes New Board Director
7M ago
Cosciens Biopharma says primary efficacy endpoint  of DETECT-trial not met
PremiumThe FlyCosciens Biopharma says primary efficacy endpoint of DETECT-trial not met
8M ago
COSCIENS Biopharma Inc (USA) trading resumes
Premium
The Fly
COSCIENS Biopharma Inc (USA) trading resumes
8M ago
COSCIENS Biopharma Inc (USA) trading halted, volatility trading pause
Premium
The Fly
COSCIENS Biopharma Inc (USA) trading halted, volatility trading pause
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100